Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocugen
Biotech
Novartis R&D chief Jay Bradner departs—Chutes & Ladders
Novartis R&D chief Bradner to depart after seven years. Pfizer fills first chief marketing officer role. I-Mab sneaks two exec changes into earnings.
Max Bayer
,
Gabrielle Masson
Sep 2, 2022 9:30am
Ocugen COVID shot will have to wait for US market after FDA hold
Nov 29, 2021 11:27am
Ocugen climbs on phase 3 COVID vaccine data
Jul 6, 2021 9:30am
Ocugen preps dry eye disease drug for phase 3
Mar 20, 2018 10:18am
Aeterna review, Allegro eye test and Ocugen orphan tag—News of Note
Aug 9, 2017 9:46am
Chutes & Ladders—BIO elects John Maraganore as new chair
Jun 22, 2017 4:08pm
